On June 27, 2024, Chimerix received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has until December 24, 2024, to regain compliance by maintaining a minimum bid price of $1.00 for at least 10 consecutive business days.If Chimerix fails to meet this requirement, it may be eligible for an additional 180-day compliance period by transferring to The Nasdaq Capital Market, provided it meets other listing standards. The company intends to actively monitor its stock price and consider options to regain compliance. Failure to regain compliance could result in delisting from Nasdaq.The notification does not immediately affect Chimerix's listing or trading on The Nasdaq Global Market. The company will explore available options to address the situation, but there is no assurance of success in regaining compliance or maintaining other Nasdaq listing criteria.

On June 27, 2024, Chimerix received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has until December 24, 2024, to regain compliance by maintaining a minimum bid price of $1.00 for at least 10 consecutive business days.If Chimerix fails to meet this requirement, it may be eligible for an additional 180-day compliance period by transferring to The Nasdaq Capital Market, provided it meets other listing standards. The company intends to actively monitor its stock price and consider options to regain compliance. Failure to regain compliance could result in delisting from Nasdaq.The notification does not immediately affect Chimerix's listing or trading on The Nasdaq Global Market. The company will explore available options to address the situation, but there is no assurance of success in regaining compliance or maintaining other Nasdaq listing criteria.